Isoorientin Inhibits Amyloid β25-35-Induced Neuronal Inflammation in BV2 Cells by Blocking the NF-κB Signaling Pathway.

Abstract

Alzheimer's disease (AD) is a severe neurodegenerative disorder. AD is pathologically characterized by the formation of intracellular neurofibrillary tangles, and extracellular amyloid plaques which were comprised of amyloid-beta (Aβ) peptides. Aβ induces neurodegeneration by activating microglia, which triggers neurotoxicity by releasing various inflammatory mediators and reactive oxygen species (ROS). Nuclear factor-kappa B (NF-κB) is expressed in human tissues including the brain and plays an important role in Aβ-mediated neuronal inflammation. Thus, the identification of molecules that inhibit the NF-κB pathway is considered an attractive strategy for the treatment and prevention of AD. Isoorientin (3',4',5,7-Tetrahydroxy-6-C-glucopyranosyl flavone; ISO), which can be extracted from several plant species, such as Philostachys and Patrinia is known to have various pharmacological activities such as anticancer, antioxidant, and antibacterial activity. However, the effect of ISO on Aβ-mediated inflammation and apoptosis in the brain has yet to be elucidated. In the present study, we investigated whether ISO regulated Aβ-induced neuroinflammation in microglial cells and further explored the underlying mechanisms. Our results showed that ISO inhibited the expression of iNOS and COX-2 induced by Aβ25-35. And, it inhibited the secretion of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). In addition, ISO reduced the ROS production in Aβ25-35-induced BV2 cells and inhibited NF-κB activation. Furthermore, ISO blocked Aβ25-35-induced apoptosis of BV2 cells. Based on these findings, we suggest that ISO represents a promising therapeutic drug candidate for the treatment and prevention of AD.

• Authors: Buyun Kim, Ki Yong Lee, Byoungduck Park
• Journal: Molecules (Basel, Switzerland) (Molecules) Vol. 26 Issue 22 (Nov 22 2021) ISSN: 1420-3049 [Electronic] Switzerland
• PMID: 34834150 (Publication Type: Journal Article)

Chemical References

• Amyloid beta-Peptides
• NF-kappa B
• Peptide Fragments
• amyloid beta-protein (25-35)
• homoorientin
• Luteolin

Topics

• Alzheimer Disease (drug therapy, metabolism, pathology)
• Amyloid beta-Peptides (metabolism)
• Animals
• Cell Line
• Inflammation (drug therapy, metabolism)
• Luteolin (chemistry, pharmacology)
• Mice
• Microglia (metabolism, pathology)
• NF-kappa B (metabolism)
• Peptide Fragments (metabolism)
• Signal Transduction (drug effects)